Febuxostat CAS 144060-53-7 Ubunyulu > 99.0% (HPLC) API Factory
Ruifu Chemical Supply Febuxostat Related Intermediates:
Febuxostat CAS 144060-53-7
I-Ethyl 2-Chloroacetoacetate CAS 609-15-4
I-4-Hydroxythiobenzamide CAS 25984-63-8
I-Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
I-Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
I-Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
I-Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
I-Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Igama leMchiza | Febuxostat |
Izithethantonye | 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylic Acid |
Inombolo yeCAS | 144060-53-7 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C16H16N2O3S |
Ubunzima beMolekyuli | 316.38 |
Indawo yokunyibilika | 207.0 ukuba 211.0℃ |
Ukuxinana | 1.31±0.1 g/cm3 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kuMhlophe oMhlophe wePowder |
Ukuchongwa | I-HPLC/IR |
Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC ngokomisiweyo) |
Ilahleko ekomisweni | <1.00% (Yomise kwi-105℃ kwi-dryer yombane evuthela umoya kude kube nobunzima obuqhubekayo) |
Iintsalela kwi-Ignition | <0.10% |
Izinto ezinxulumeneyo | |
Ukungacoceki okuphezulu okukodwa | <0.30% |
Ukungcola ngokupheleleyo | <1.00% |
Iikloridi | <0.04% |
Iintsimbi ezinzima | <20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | API |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-Febuxostat (i-CAS: 144060-53-7), ethengiswa phantsi kwegama le-brand Uloric kunye ne-Adenuric phakathi kwabanye, iyeza elisetyenziselwa ixesha elide ukunyanga i-gout ngenxa yamanqanaba aphezulu e-uric acid.Ngokuqhelekileyo kucetyiswa kuphela kubantu abangakwaziyo ukuthatha i-allopurinol.Xa kuqalwa ekuqaleni, amayeza afana ne-NSAID ahlala ecetyiswa ukukhusela i-gout flares.Ithathwa ngomlomo.I-Febuxostat yavunywa ukusetyenziswa kwezonyango kwi-European Union kwi-2008 nase-United States ngo-2009. I-Febuxostat isetyenziselwa ukuphatha i-gout engapheliyo kunye ne-hyperuricemia.I-Febuxostat inconywa kuphela kubantu abangakwazi ukunyamezela i-allopurinol.